<DOC>
	<DOCNO>NCT00210431</DOCNO>
	<brief_summary>The purpose study provide information regard risk benefit Dysport market indication .</brief_summary>
	<brief_title>Post Marketing Surveillance Study Dysport</brief_title>
	<detailed_description />
	<mesh_term>Cerebral Palsy</mesh_term>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Blepharospasm</mesh_term>
	<mesh_term>Hemifacial Spasm</mesh_term>
	<mesh_term>Equinus Deformity</mesh_term>
	<mesh_term>Clubfoot</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<criteria>adult child age 2 year schedule receive Dysport per normal treatment practice , conformance country 's Summary Product Characteristics history hypersensitivity Dysport drug similar chemical structure treatment investigational drug within last 30 day survey entry</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>